FR2266740B3 - - Google Patents

Info

Publication number
FR2266740B3
FR2266740B3 FR7510302A FR7510302A FR2266740B3 FR 2266740 B3 FR2266740 B3 FR 2266740B3 FR 7510302 A FR7510302 A FR 7510302A FR 7510302 A FR7510302 A FR 7510302A FR 2266740 B3 FR2266740 B3 FR 2266740B3
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7510302A
Other versions
FR2266740A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Rega VZW
Original Assignee
Stichting Rega VZW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega VZW filed Critical Stichting Rega VZW
Publication of FR2266740A1 publication Critical patent/FR2266740A1/fr
Application granted granted Critical
Publication of FR2266740B3 publication Critical patent/FR2266740B3/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7510302A 1974-04-03 1975-04-02 Expired FR2266740B3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7404589A NL7404589A (nl) 1974-04-03 1974-04-03 Werkwijze voor het stabiliseren van interferon.

Publications (2)

Publication Number Publication Date
FR2266740A1 FR2266740A1 (fr) 1975-10-31
FR2266740B3 true FR2266740B3 (fr) 1977-12-16

Family

ID=19821109

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7510302A Expired FR2266740B3 (fr) 1974-04-03 1975-04-02

Country Status (11)

Country Link
US (1) US3981991A (fr)
JP (1) JPS5132725A (fr)
AU (1) AU7951275A (fr)
BE (1) BE826889A (fr)
DE (1) DE2514537A1 (fr)
DK (1) DK139775A (fr)
FI (1) FI750951A (fr)
FR (1) FR2266740B3 (fr)
NL (1) NL7404589A (fr)
NO (1) NO751118L (fr)
SE (1) SE7503769L (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
WO1986001723A1 (fr) * 1984-09-21 1986-03-27 Vsesojuzny Nauchno-Issledovatelsky Institut Osobo Procede de rectification d'interferon leukocytique humain
ES500966A0 (es) 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
IL74093A0 (en) * 1984-01-23 1985-04-30 Takeda Chemical Industries Ltd Stable composition of gamma-interferon
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JP2577742B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4950470A (en) * 1986-10-06 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing interferon-gamma
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano

Also Published As

Publication number Publication date
DK139775A (fr) 1975-10-04
BE826889A (nl) 1975-09-22
FI750951A (fr) 1975-10-04
SE7503769L (sv) 1975-10-06
US3981991A (en) 1976-09-21
JPS5132725A (fr) 1976-03-19
NO751118L (fr) 1975-10-06
NL7404589A (nl) 1975-10-07
FR2266740A1 (fr) 1975-10-31
DE2514537A1 (de) 1975-10-09
AU7951275A (en) 1976-09-30

Similar Documents

Publication Publication Date Title
FR2266740B3 (fr)
BR7501663A (fr)
AU7459374A (fr)
AU495028B2 (fr)
JPS50133496A (fr)
BG22015A1 (fr)
CH572750A5 (fr)
BE833391A (fr)
BG23065A1 (fr)
AU481101A (fr)
AU480625A (fr)
AU480143A (fr)
BG19667A1 (fr)
BG19896A1 (fr)
BG19982A1 (fr)
BG20022A1 (fr)
BG20237A1 (fr)
BG20425A1 (fr)
BG20446A1 (fr)
BG20857A1 (fr)
BG21135A1 (fr)
BG21493A1 (fr)
BG26511A3 (fr)
BG27078A3 (fr)
BG22275A1 (fr)